These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. [An experimental study of the effect of biopolymers on the course of an inflammatory process in the oral mucosa]. Khomenko LA; Antonishin BV; Rakhniĭ ZhI Stomatologiia (Mosk); 1992; (2):20-3. PubMed ID: 1412533 [No Abstract] [Full Text] [Related]
63. Long-acting delivery systems for narcotic antagonists. 1. Woodland JH; Yolles S; Blake DA; Helrich M; Meyer FJ J Med Chem; 1973 Aug; 16(8):897-901. PubMed ID: 4745832 [No Abstract] [Full Text] [Related]
64. Sustained and controlled release of neuroactive substances in the CNS by encapsulation into implantable polymers. Peterson GM Neurobiol Aging; 1989; 10(5):639-40; discussion 648-50. PubMed ID: 2812244 [TBL] [Abstract][Full Text] [Related]
65. Preparation and in vitro evaluation of a sustained-action suspension of dextromethorphan. Smith WE; Buehler JD; Robinson MJ J Pharm Sci; 1970 Jun; 59(6):776-9. PubMed ID: 5423075 [No Abstract] [Full Text] [Related]
66. New approach to development and manufacture of enteric compression coatings. Srinivas R; DeKay HG; Banker GS J Pharm Sci; 1966 Mar; 55(3):335-40. PubMed ID: 5960182 [No Abstract] [Full Text] [Related]
67. Acute toxicity as a method of assessing sustained release preparations. SHENOY KG; GRICE HC; CAMPBELL JA Toxicol Appl Pharmacol; 1960 Jan; 2():100-10. PubMed ID: 14445819 [No Abstract] [Full Text] [Related]
69. Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies. Bisaga A; Mannelli P; Sullivan MA; Vosburg SK; Compton P; Woody GE; Kosten TR Am J Addict; 2018 Apr; 27(3):177-187. PubMed ID: 29596725 [TBL] [Abstract][Full Text] [Related]
70. Treating Opioid Dependence With Injectable Extended-Release Naltrexone (XR-NTX): Who Will Respond? Nunes EV; Krupitsky E; Ling W; Zummo J; Memisoglu A; Silverman BL; Gastfriend DR J Addict Med; 2015; 9(3):238-43. PubMed ID: 25901451 [TBL] [Abstract][Full Text] [Related]
71. Biodegradable polymers in controlled drug delivery. Heller J Crit Rev Ther Drug Carrier Syst; 1984; 1(1):39-90. PubMed ID: 6400195 [TBL] [Abstract][Full Text] [Related]
72. The development of sustained action preparations of narcotic antagonists. Willette RE NIDA Res Monogr; 1976 Sep; (9):31-4. PubMed ID: 1004531 [No Abstract] [Full Text] [Related]
73. Background on animal testing in the drug delivery systems program. Dewey WL NIDA Res Monogr; 1981; 28():69-76. PubMed ID: 6791014 [TBL] [Abstract][Full Text] [Related]
74. Sustained release of naltrexone from glyceride implants. Sullivan MF; Kalkwarf DR Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):27-32. PubMed ID: 967232 [TBL] [Abstract][Full Text] [Related]
75. Narcotic antagonists: the search for long-acting preparations: introduction. Willette RE Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):1-5. PubMed ID: 827708 [No Abstract] [Full Text] [Related]
76. Development of Chronomers tm for narcotic antagonists. Capozza RC; Schmitt EE; Seńdelbeck LR Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):39-42. PubMed ID: 967234 [TBL] [Abstract][Full Text] [Related]